Unlocking the Link Between Gut Microbiota and Psychopathological Insights in Anorexia Nervosa: A Systematic Review
European Eating Disorders Review,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 30, 2025
This
systematic
review
explores
the
associations
between
qualitative/quantitative
changes
in
gut
microbiota
and
psychopathological
symptoms
or
other
clinical
features
patients
with
eating
disorders
(EDs).
Secondary
outcomes
include
exploring
EDs
potential
relationships
psychotropic
drug
use.
A
search
was
conducted
across
biomedical
databases
from
inception
to
June
2024
according
PRISMA
guidelines.
The
risk
of
bias
assessed,
a
narrative
synthesis
performed
due
heterogeneity
outcomes.
Only
findings
related
anorexia
nervosa
(AN)
were
identified.
Ten
studies,
which
seven
longitudinal,
two
cross-sectional,
one
interventional
(N
=
350
AN,
304
HCs),
included.
Despite
no
clear
links
diversity
metrics
being
observed,
specific
taxa
belonging
phylum
Firmicutes,
such
as
Clostridium,
Roseburia,
Lactobacillus,
Faecalibacterium,
Bifidobacterium
Actinobacteriota
correlated
ED
psychopathology,
including
anxiety
depressive
symptoms.
Changes
symptoms,
well
altered
behaviours
by
modulating
inflammation
insulin
pathways
through
short-chain
fatty
acids
(SCFAs),
that
also
lead
neurotransmitter
imbalances.
Further
studies
are
required
replicate
these
finding
explore
whether
similar
patterns
observed
EDs.
Language: Английский
Evaluating the Efficacy of Secondary Metabolites in Antibiotic-Induced Dysbiosis: A Narrative Review of Preclinical Studies
Corina Andrei,
No information about this author
Anca Zanfirescu,
No information about this author
Victor-Pierre Ormeneanu
No information about this author
et al.
Antibiotics,
Journal Year:
2025,
Volume and Issue:
14(2), P. 138 - 138
Published: Feb. 1, 2025
Background/Objectives:
Drug-induced
dysbiosis,
particularly
from
antibiotics,
has
emerged
as
a
significant
contributor
to
chronic
diseases
by
disrupting
gut
microbiota
composition
and
function.
Plant-derived
secondary
metabolites,
such
polysaccharides,
polyphenols,
alkaloids,
saponins,
show
potential
in
mitigating
antibiotic-induced
dysbiosis.
This
review
aims
consolidate
evidence
preclinical
studies
on
the
therapeutic
effects
of
metabolites
restoring
microbial
balance,
emphasizing
their
mechanisms
efficacy.
Methods:
A
narrative
was
conducted
using
PubMed,
Scopus,
Web
Science.
Studies
were
selected
based
specific
inclusion
criteria,
focusing
animal
models
treated
with
for
The
search
terms
included
“gut
microbiota”,
“antibiotics”,
“secondary
metabolites”.
Data
extraction
focused
alterations,
metabolite-specific
effects,
action.
Relevant
findings
systematically
analyzed
summarized.
Results:
Secondary
demonstrated
diverse
impact
dysbiosis
modulating
composition,
reducing
inflammation,
supporting
host
biological
markers.
Polysaccharides
polyphenols
restored
Firmicutes/Bacteroidetes
ratio,
increased
beneficial
taxa
Lactobacillus
Bifidobacterium,
suppressed
pathogenic
bacteria
like
Escherichia-Shigella.
Metabolites
triterpenoid
saponins
enhanced
barrier
integrity
upregulating
tight
junction
proteins,
while
alkaloids
reduced
inflammation
proinflammatory
cytokines
(e.g.,
TNF-α,
IL-1β).
These
also
improved
short-chain
fatty
acid
production,
which
is
crucial
systemic
health.
While
primary
focus,
other
drug
classes
PPIs,
metformin)
require
further
investigation.
Conclusions:
promise
managing
improving
Future
research
should
explore
applicability
types
drug-induced
validate
human
enhance
clinical
relevance.
Language: Английский
Oropharyngeal microbiota in patients with psychotic disorders: A scoping review on compositional and functional alterations
Mauro Scala,
No information about this author
María del Rocío González Soltero,
No information about this author
Á. Esteban
No information about this author
et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Journal Year:
2025,
Volume and Issue:
137, P. 111288 - 111288
Published: Feb. 7, 2025
Language: Английский
Microbiome-Gut-Brain Profiles in Schizophrenia and Their Potential Link to Cognitive Performance: Findings from a Case–Control Study
Hui Wu,
No information about this author
Xu Jiawei,
No information about this author
Zhi Wen
No information about this author
et al.
Schizophrenia Bulletin,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 25, 2025
Increasing
evidence
indicates
the
role
of
microbiome-gut-brain
axis
in
schizophrenia
(SZ).
However,
few
studies
have
examined
potential
links
among
gut
microbiome,
brain
structure
and
function,
clinical
manifestation
SZ
patients,
effects
prolonged
antipsychotic
treatment
are
often
neglected.
A
total
171
participants
were
enrolled,
including
27
drug-naïve
first-episode
patients
(FSZ),
72
chronically
antipsychotics-treated
(CSZ),
healthy
controls
(HCs).
Multi-omics
data,
fecal
16S
rRNA
sequencing,
structural
functional
imaging
analyses,
assessments
psychotic
symptoms
cognitive
obtained
to
characterize
patients.
Correlation
mediation
analyses
conducted
assess
relationships
neuroimaging
features,
manifestations.
Compared
with
HCs,
3
key
diagnostic
genera
identified
SZ,
characterized
by
decreased
abundance
Blautia
(FSZ/CSZ
<
HCs)
increased
Proteus
Arthrobacter
(FSZ
>
CSZ
HCs).
This
microbial
dysbiosis
was
accompanied
down-regulated
bile
acids
biosynthesis
up-regulated
lipid
metabolism.
Further
revealed
a
tripartite
relationship
genera,
altered
separate
subgroups.
Importantly,
higher
may
result
lower
scores
on
several
domains
disrupting
gray
matter
volume
regional
homogeneity
specific
regions.
work
advances
our
knowledge
microbiota-gut-brain
disturbances
its
performance
SZ.
Moreover,
results
highlight
importance
considering
exposure
gut-brain
research.
Language: Английский
Gut microbiome characteristics in individuals across different stages of schizophrenia spectrum disorders: A systematic review and meta-analysis
Neuroscience & Biobehavioral Reviews,
Journal Year:
2025,
Volume and Issue:
unknown, P. 106167 - 106167
Published: April 1, 2025
Language: Английский
Gut Microbiota in Immuno-Oncology: A Practical Guide for Medical Oncologists With a Focus on Antibiotics Stewardship
American Society of Clinical Oncology Educational Book,
Journal Year:
2025,
Volume and Issue:
45(3)
Published: April 22, 2025
The
gut
microbiota
has
emerged
as
a
critical
determinant
of
immune
checkpoint
inhibitor
(ICI)
efficacy,
resistance,
and
toxicity.
Retrospective
prospective
studies
profiling
the
taxonomic
composition
intestinal
microbes
patients
treated
with
ICI
have
revealed
specific
microbial
signatures
associated
response.
By
contrast,
dysbiosis,
which
can
be
caused
by
chronic
inflammatory
processes
(such
cancer)
or
comedications,
is
risk
factor
resistance
to
ICI.
Recent
large-scale
meta-analyses
confirmed
that
antibiotic
(ATB)
use
before
during
therapy
alters
repertoire
significantly
shortens
overall
survival,
even
after
adjusting
for
prognostic
factors.
These
results
underscore
importance
implementing
ATB
stewardship
recommendations
in
routine
oncology
practice.
Microbiota-centered
interventions
are
now
being
explored
treat
dysbiosis
optimize
responses.
Early-phase
clinical
trials
evaluating
fecal
transplantation
(FMT)
from
responders
healthy
donors
shown
this
approach
safe
provided
preliminary
data
on
potential
efficacy
overcome
both
primary
secondary
melanoma,
non–small
cell
lung
cancer,
renal
carcinoma.
More
targeted
including
live
bacterial
products
Clostridium
butyricum
Akkermansia
massiliensis
represent
novel
microbiome-based
adjunct
therapies.
Likewise,
dietary
interventions,
such
high-fiber
diets,
promise
enhancing
activity.
In
ASCO
Educational
Book,
we
summarize
current
state-of-the-evidence
relevance
cancer
immunotherapy
provide
practical
guide
stewardship.
Language: Английский
Schizophrenia and antipsychotic medications present distinct and shared gut microbial composition: A meta-analysis
Cheng Wei-rong,
No information about this author
Mengjie Zhao,
No information about this author
Xinyun Zhang
No information about this author
et al.
Schizophrenia Research,
Journal Year:
2024,
Volume and Issue:
274, P. 257 - 268
Published: Oct. 9, 2024
Language: Английский
Blockade of Voltage‐Gated K+ Channels in Rabbit Coronary Arterial Smooth Muscle Cells by the Antipsychotic Drug Zotepine
Wenwen Zhuang,
No information about this author
Minju Park,
No information about this author
Junsu Jeong
No information about this author
et al.
Journal of Applied Toxicology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 9, 2024
ABSTRACT
Zotepine
is
a
second‐generation
antipsychotic
that
demonstrates
significant
efficacy
in
antagonizing
D
2
and
5‐HT
2A
receptors.
Although
clinical
investigations
have
shown
administering
zotepine
associated
with
an
increased
prevalence
of
hyperglycemia
heightened
risk
cardiovascular
disease,
the
side
effects
on
voltage‐gated
K
+
(Kv)
channels
not
been
established.
suppressed
vascular
Kv
rabbit
coronary
arterial
smooth
muscle
cells
concentration‐dependent
manner,
IC
50
5.3
±
0.4
μM
Hill
coefficient
1.6
0.2.
The
decay
rate
inactivation
was
significantly
accelerated
by
zotepine.
Applying
(10
μM)
shifted
steady‐state
curve
negative
direction.
train
pulses
at
1
Hz
resulted
progressive
increase
blockage
currents
Furthermore,
prolonged
recovery
time
from
inactivation.
pretreatment
Kv2.1
subtype
inhibitor
stromatoxin‐1
Kv7
linopirdine
did
change
degree
zotepine‐induced
inhibition
currents,
Kv1.5
channel
DPO‐1
decreased
inhibitory
currents.
also
induced
membrane
depolarization.
These
results
indicate
inhibits
(mainly
subtype)
dose‐,
time‐,
use
(state)‐dependent
manners
changing
curve.
Language: Английский